The effects of chronic, low-dose administration of the cannabinoid THC - the main psychoactive ingredient in marijuana - on neurocognitive behavior and gene expression patterns in young and old mice are reported online in Nature Medicine this week. These preclinical findings suggest that, at least in mice, THC treatment can ameliorate age-related learning and memory deficits. However, it is too premature to determine whether these effects might also apply to other species, including humans.
Psychoactive compounds found in marijuana, such as the cannabinoids Δ9-tetrahydrocannabinol (THC) or cannabidiol, exert their actions on the nervous system by interacting with endogenous cannabinoid (endocannabinoid) receptors. The potential use of cannabinoids to treat human neurological conditions such as epilepsy or pain remains an active, yet controversial, area of research. Although cannabinoid use is generally thought to elicit acute cognitive impairments and might carry a high potential for abuse, its effects on the aged brain are not well characterized. Previous work has found that the brain endocannabinoid system is downregulated during the course of normal aging.
Andreas Zimmer and colleagues examined the effects of chronic, low-dose THC administration in young (two months old), mature (12 months old) and old (18 months old) rodents. They find that although treatment impaired behavioral performance on learning and memory tasks in young mice, similar treatment actually improved learning and memory in mature and old mice. These changes in behavior in older animals were associated with a restoration of global hippocampal gene expression patterns back to a state similar to that observed in young animals.
Essential next steps include additional preclinical investigation to more thoroughly document the time course and persistence of these effects, as well as to determine their mechanistic basis. Furthermore, it remains to be determined whether similar age-dependent effects would be observed in other animal models that exhibit age-related cognitive decline more similar to that observed in humans (such as in nonhuman primates).
Epidemiology: Assessing non-pharmaceutical interventions in reducing COVID-19 spreadNature Human Behaviour
Epidemiology: A website to assess COVID-19 event risk in the US in real timeNature Human Behaviour